157
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Astaxanthin attenuates cardiovascular dysfunction associated with deoxycorticosterone acetate-salt-induced hypertension in rats

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 382-395 | Received 27 Jan 2022, Accepted 05 Mar 2022, Published online: 24 Mar 2022

References

  • Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224–60.
  • Gupta R, Hypertension: XD.The most important non communicable disease risk factor in India. Indian Heart J. 2018;70(4):565–72.doi:10.1016/j.ihj.2018.02.003.
  • Wang D, Luo Y, Myakala K, Orlicky DJ, Dobrinskikh E, Wang X, Levi M . Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats. Scientific Reports. 2017;7(1):9793.doi:10.1038/s41598-017-09470-0.
  • Pestana-Oliveira N, Nahey DB, Johnson T, Collister JP.Development of the Deoxycorticosterone Acetate (DOCA)-salt Hypertensive Rat Model. Bio-protocol. 2020;10(15):e3708–e.doi:10.21769/BioProtoc.3708.
  • Guyenet PG.The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7(5):335–46.doi:10.1038/nrn1902.
  • Zhou Y, Luo P, Chang -H-H, Huang H, Yang T, Dong Z, Wang C-Y, Wang M-H . Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension. Kidney International. 2008;74(8):1040–48.doi:10.1038/ki.2008.300.
  • González A, Ravassa S, López B, Moreno MU, Beaumont J, San José G, Querejeta R, Bayés-Genís A, Díez J . Myocardial Remodeling in Hypertension. Hypertension. 2018;72(3):549–58.doi:10.1161/HYPERTENSIONAHA.118.11125.
  • Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ.Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63(1):10–21.doi:10.1016/j.pcad.2019.11.009.
  • Hou Y, Yuan P, Fu Y, Zhang Q, Gao L, Wei Y, Zheng X,Feng W . Geniposide from Gardenia jasminoides var. Radicans Makino Attenuates Myocardial Injury in Spontaneously Hypertensive Rats via Regulating Apoptotic and Energy Metabolism Signalling Pathway. Drug Design, Development and Therapy 2021;15:949–62.
  • Rodrigo R, González J, Paoletto F.The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res. 2011;34(4):431–40.doi:10.1038/hr.2010.264.
  • Incalza M Angela, D'Oria R, Natalicchio A, Perrini S, Laviola L and Giorgino F. (2018). Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascular Pharmacology, 100 1–19. 10.1016/j.vph.2017.05.005
  • Touyz RM, Rios FJ, Alves-Lopes R, Neves KB, Camargo LL, Montezano AC.Oxidative Stress: a Unifying Paradigm in Hypertension. Can J Cardiol. 2020;36(5):659–70.doi:10.1016/j.cjca.2020.02.081.
  • Gulladawan J-O, Akarachai T, Weerapon S, Poungrat P, Veerapol K, Ketmanee S, Chakree T, Upa K . Sang-Yod rice bran hydrolysates alleviate hypertension, endothelial dysfunction, vascular remodeling, and oxidative stress in nitric oxide deficient hypertensive rats. Asian Pacific Journal of Tropical Biomedicine 2021 . 11;1:10–19 .
  • Tsai S, Hollenbeck ST, Ryer EJ, Edlin R, Yamanouchi D, Kundi R, Wang C, Liu B, Kent KC . TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol. 2009;297(2):H540–9.doi:10.1152/ajpheart.91478.2007.
  • Lefer AM, Ma XL, Weyrich AS, Scalia R.Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc Natl Acad Sci U S A. 1993;90(3):1018–22.doi:10.1073/pnas.90.3.1018.
  • Grujic-Milanovic J, Miloradovic Z, Jovovic D, Jacevic V, Milosavljevic I, Milanovic SD, Mihailovic-Stanojevic N . The red wine polyphenol, resveratrol improves hemodynamics, oxidative defence and aortal structure in essential and malignant hypertension. Journal of Functional Foods. 2017;34:266–76.
  • Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ.BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proceedings of the National Academy of Sciences of the United States of America. 1991;88(16):6961–65.doi:10.1073/pnas.88.16.6961.
  • Xia W, Tang N, Kord-Varkaneh H, Low TY, Tan SC, Wu X, Zhu Y . The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: a meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105113.
  • Kim SH, Kim H.Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review. Nutrients. 2018;10(9):1137.doi:10.3390/nu10091137.
  • Fakhri S, Abbaszadeh F, Dargahi L, Jorjani M.Astaxanthin: a mechanistic review on its biological activities and health benefits. Pharmacol Res. 2018;136:1–20.doi:10.1016/j.phrs.2018.08.012.
  • Monroy-Ruiz J, Sevilla M, Carrón R, Montero MJ.Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats. Pharmacol Res. 2011;63(1):44–50.doi:10.1016/j.phrs.2010.09.003.
  • National Research Council Committee for the Update of the Guide for the C, Use of Laboratory A. The National Academies Collection: reports funded by National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US) Copyright © 2011, National Academy of Sciences; 2011.
  • Titze J, Luft FC, Bauer K, Dietsch P, Lang R, Veelken R, Wagner H, Eckardt K-U, Hilgers KF . Extrarenal Na+ Balance, Volume, and Blood Pressure Homeostasis in Intact and Ovariectomized Deoxycorticosterone-Acetate Salt Rats. Hypertension. 2006;47(6):1101–07.doi:10.1161/01.HYP.0000221039.17735.1a.
  • Safaeian L, Emami R, Hajhashemi V, Haghighatian Z.Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats. Biomed Pharmacother. 2018;100:147–55.doi:10.1016/j.biopha.2018.01.107.
  • Tripathi DN, Jena GB.Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells. Toxicology. 2008;248(2–3):96–103.doi:10.1016/j.tox.2008.03.015.
  • Husková Z, Kikerlová S, Sadowski J, Alánová P, Sedláková L, Papoušek F, Neckář J . Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury. Frontiers in Pharmacology. 2021;12:1296.
  • Zorniak M, Mitrega K, Bialka S, Porc M, Krzeminski TF.Comparison of thiopental, urethane, and pentobarbital in the study of experimental cardiology in rats in vivo. Journal of Cardiovascular Pharmacology. 2010;56(1):38–44.doi:10.1097/FJC.0b013e3181dd502c.
  • El-Garawani IM, Hassab El-Nabi S.Increased sensitivity of apoptosis detection using direct DNA staining method and integration of acridine Orange as an alternative safer fluorescent dye in agarose gel electrophoresis and micronucleus test. Cjpas. 2016;10(2):3865–71.
  • Hassab El-Nabi S, Elhassaneen Y.Detection of DNA damage, molecular apoptosis and production of home-made ladder by using simple techniques. Biotechnology. 2008;7(3):514–22.doi:10.3923/biotech.2008.514.522.
  • Hassan A.Amelioration of some manifestations of metabolic syndrome in rats by allopurinol irrespective of lowering serum uric acid level: role of adiponectin. Egypt J Basic Clin Pharmacol. 2013;3:83–94.
  • Bancroft JDGM. Theory and practice of histological techniques. London; New York: Churchill Livingstone; 2002.
  • Happerfield L, Bobrow L, Bains R, Miller K.Peroxidase labelling immunocytochemistry: a comparison of eleven commercially-available avidin-biotin systems. British Journal of Biomedical Science. 1993;50(1):21–26.
  • Gomez-Sanchez EP.DOCA/Salt: much More Than a Model of Hypertension. J Cardiovasc Pharmacol. 2019;74(5):369–71.doi:10.1097/FJC.0000000000000753.
  • Bouvier M, de Champlain J.Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats. J Auton Nerv Syst. 1986;15(2):191–95.doi:10.1016/0165-1838(86)90014-7.
  • Hussein G, Nakamura M, Zhao Q, Iguchi T, Goto H, Sankawa U, Watanabe H . Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol Pharm Bull. 2005;28(1):47–52.doi:10.1248/bpb.28.47.
  • Hussein G, Goto H, Oda S, Iguchi T, Sankawa U, Matsumoto K, Watanabe H . Antihypertensive potential and mechanism of action of astaxanthin: II. Vascular Reactivity and Hemorheology in Spontaneously Hypertensive Rats. Biological & Pharmaceutical Bulletin 2005;28:967–71.
  • Lee T-M, Lin M-S, Chou T-F, Tsai C-H, Chang N-C.Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 2005;289(1):H220–H7.doi:10.1152/ajpheart.00417.2004.
  • Asaikumar L, Vennila L, Akila P, Sivasangari S, Kanimozhi K, Premalatha V, Sindhu G . Expression of Concern: preventive effect of nerolidol on isoproterenol induced myocardial damage in Wistar rats: evidences from biochemical and histopathological studies. Drug Development Research. 2019;80(6):814–23.doi:10.1002/ddr.21564.
  • Ide N, Lau BH.Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. Journal of Pharmacy and Pharmacology. 1997;49(9):908–11.doi:10.1111/j.2042-7158.1997.tb06134.x.
  • Ibrahim MA, Eraqi MM, Alfaiz FA.Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats. Heliyon. 2020;6(1):e03209.doi:10.1016/j.heliyon.2020.e03209.
  • Hussein MA.Cardioprotective effects of astaxanthin against isoproterenol-induced cardiotoxicity in rats. J Nutr Food Sci. 2015;5(335):2.
  • Wang H, Sun J, Jia Z, Yang T, Xu L, Zhao B, Yu K, Wang R . Nitrooleic acid attenuates lipid metabolic disorders and liver steatosis in DOCA-salt hypertensive mice. PPAR Research. 2015 (2015) ;2015.
  • Girard A, Madani S, El Boustani ES, Belleville J, Prost J.Changes in lipid metabolism and antioxidant defense status in spontaneously hypertensive rats and Wistar rats fed a diet enriched with fructose and saturated fatty acids. Nutrition. 2005;21(2):240–48.doi:10.1016/j.nut.2004.04.022.
  • Nakano A, Inoue N, Sato Y, Nishimichi N, Takikawa K, Fujita Y, Kakino A, Otsui K, Yamaguchi S, Matsuda H, et al. LOX-1 mediates vascular lipid retention under hypertensive state. Journal of Hypertension. 2010;28(6):1273–80.doi:10.1097/HJH.0b013e32833835d4.
  • Jannel S, Caro Y, Bermudes M, Petit T.Novel insights into the biotechnological production of Haematococcus pluvialis-derived astaxanthin: advances and key challenges to allow its industrial use as novel food ingredient. Journal of Marine Science and Engineering. 2020;8(10):789.doi:10.3390/jmse8100789.
  • Yang Y, Seo JM, Nguyen A, Pham TX, Park HJ, Park Y, Kim B, Bruno RS, Lee J . Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. The Journal of Nutrition. 2011;141(9):1611–17.doi:10.3945/jn.111.142109.
  • Puddu P, Puddu GM, Cravero E, Rosati M, Muscari A.The molecular sources of reactive oxygen species in hypertension. Blood Press. 2008;17(2):70–77.doi:10.1080/08037050802029954.
  • Kato T, Kasai T, Sato A, Ishiwata S, Yatsu S, Matsumoto H, Shitara J, Murata A, Shimizu M, Suda S, et al. Effects of 3-Month Astaxanthin Supplementation on Cardiac Function in Heart Failure Patients with Left Ventricular Systolic Dysfunction-A Pilot Study. Nutrients. 2020;12(6):6.doi:10.3390/nu12061896.
  • Fassett RG, Coombes JS.Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs. 2011;9(3):447–65.doi:10.3390/md9030447.
  • Kidd P.Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev. 2011;16(4):355–64.
  • Cui G, Li L, Xu W, Wang M, Jiao D, Yao B, Xu K, Chen Y, Yang S, Long M, et al. Astaxanthin protects ochratoxin A-induced oxidative stress and apoptosis in the heart via the Nrf2 pathway. Oxidative Medicine and Cellular Longevity. 2020 ;(2020) ;2020.
  • Visioli F, Artaria C.Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps. Food Funct. 2017;8(1):39–63.doi:10.1039/C6FO01721E.
  • Wang D, Luo Y, Myakala K, Orlicky DJ, Dobrinskikh E, Wang X, Takumi T, Hashimoto R, Otani H, Pazour GJ, et al. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats. Scientific Reports. 2017;7(1):1–10.doi:10.1038/s41598-016-0028-x.
  • Del Mauro JS, Prince PD, Plantamura YS, Allo MA, Parola L, Machulsky NF, Morettón, MA, Bin, EP, González, GE, Bertera, FM, et al. Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats. Hypertension Research. 2021;44(7):791–802.doi:10.1038/s41440-021-00630-4.
  • Edgley AJ, Krum H, Kelly DJ.Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor‐β. Cardiovascular Therapeutics. 2012;30(1):e30–e40.doi:10.1111/j.1755-5922.2010.00228.x.
  • Cotter G, Metra M, Milo‐Cotter O, Dittrich HC, Gheorghiade M.Fluid overload in acute heart failure—re‐distribution and other mechanisms beyond fluid accumulation. European Journal of Heart Failure. 2008;10(2):165–69.doi:10.1016/j.ejheart.2008.01.007.
  • Díez J.Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions. American Journal of Cardiovascular Drugs. 2014;14(4):275–85.doi:10.1007/s40256-014-0069-0.
  • Davis GK, Fehrenbach DJ, Madhur MS.Interleukin 17A: key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target. Current Hypertension Reports. 2021;23(3):1–9.doi:10.1007/s11906-021-01128-7.
  • Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S . Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Investigative Ophthalmology & Visual Science. 2003;44(6):2694–701.doi:10.1167/iovs.02-0822.
  • Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan X-M.Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. Journal of Molecular and Cellular Cardiology. 2004;37(5):969–78.doi:10.1016/j.yjmcc.2004.07.009.
  • Nakao R, Nelson OL, Park JS, Mathison BD, Thompson PA, Chew BP.Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Research. 2010;30(7):2721–25.
  • Wang W, Liu T, Liu Y, Yu L, Yan X, Weng W, Lu X, Zhang C . Astaxanthin attenuates alcoholic cardiomyopathy via inhibition of endoplasmic reticulum stress-mediated cardiac apoptosis. Toxicology and Applied Pharmacology. 2021;412:115378.
  • Pan X, Zhang K, Shen C, Wang X, Wang L, Huang -Y-Y.Astaxanthin promotes M2 macrophages and attenuates cardiac remodeling after myocardial infarction by suppression inflammation in rats. Chinese Medical Journal. 2020;133(15):1786–97.doi:10.1097/CM9.0000000000000814.
  • Chen Z, Xiao J, Liu H, Yao K, Hou X, Cao Y, Liu X . Astaxanthin attenuates oxidative stress and immune impairment in d -galactose-induced aging in rats by activating the Nrf2/Keap1 pathway and suppressing the NF-κB pathway. Food & Function. 2020;11(9):8099–111.doi:10.1039/D0FO01663B.
  • Priyadarshini L, Aggarwal A.Astaxanthin inhibits cytokines production and inflammatory gene expression by suppressing IκB kinase-dependent nuclear factor κB activation in pre and postpartum Murrah buffaloes during different seasons. Veterinary World. 2018;11(6):782.doi:10.14202/vetworld.2018.782-788.
  • Tea B-S, Dam T-V, Moreau P, Hamet P, deBlois D.Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats: temporal regulation and spatial heterogeneity. Hypertension. 1999;34(2):229–35.doi:10.1161/01.HYP.34.2.229.
  • Quadrilatero J, Rush JW.Increased DNA fragmentation and altered apoptotic protein levels in skeletal muscle of spontaneously hypertensive rats. Journal of Applied Physiology. 2006;101(4):1149–61.doi:10.1152/japplphysiol.00194.2006.
  • Fortuño MA, Ravassa S, Fortuño A, Zalba G, Díez J.Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management. Hypertension. 2001;38(6):1406–12.doi:10.1161/hy1201.099615.
  • Santocono M, Zurria M, Berrettini M, Fedeli D, Falcioni G.Lutein, zeaxanthin and astaxanthin protect against DNA damage in SK-N-SH human neuroblastoma cells induced by reactive nitrogen species. Journal of Photochemistry and Photobiology B: Biology. 2007;88(1):1–10.doi:10.1016/j.jphotobiol.2007.04.007.
  • Sudharshan S, Dyavaiah M.Astaxanthin protects oxidative stress mediated DNA damage and enhances longevity in Saccharomyces cerevisiae. Biogerontology. 2021;22(1):81–100.doi:10.1007/s10522-020-09904-9.
  • Silambarasan T, Raja B.Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 2012;679(1–3):81–89.doi:10.1016/j.ejphar.2011.12.040.
  • Beswick RA, Dorrance AM, Leite R, Webb RC.NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 2001;38(5):1107–11.doi:10.1161/hy1101.093423.
  • Amani H, Habibey R, Shokri F, Hajmiresmail SJ, Akhavan O, Mashaghi A, Pazoki-Toroudi H . Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Scientific Reports. 2019;9(1):1–15.doi:10.1038/s41598-019-42633-9.
  • Wang P, Wang SC, Yang H, Lv C, Jia S, Liu X, Wang X, Meng D, Qin D, Zhu H, et al. Therapeutic potential of oxytocin in atherosclerotic cardiovascular disease: mechanisms and signaling pathways. Frontiers in Neuroscience. 2019;13:454.
  • Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL.Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ETA receptors. Hypertension. 2002;39(2):679–84.doi:10.1161/hy0202.103481.
  • Shen M, Chen K, Lu J, Cheng P, Xu L, Dai W, Wang F, He L, Zhang Y, ChengfenW, et al. Protective effect of astaxanthin on liver fibrosis through modulation of TGF-1 expression and autophagy. Mediators of Inflammation. 2014 (2014) ;954502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.